Johnson & Johnson operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Johnson & Johnson with three other
major healthcare and pharmaceutical companies:
Bristol-Myers Squibb Company
sales of $20.78 billion
of which 100%
Baxter International Inc.
of which 54%
was Americas), and
based in Switzerland
(49.16 billion Swiss Francs [US$50.26 billion]
of which 66%
was Innovative Medicines).
During the year ended December of 2017, sales at
Johnson & Johnson were $76.45 billion.
increase of 6.3%
versus 2016, when the company's sales were $71.89 billion.
Sales of Pharmaceutical saw an increase
8.3% in 2017, from
$33.46 billion to $36.26 billion.